Press Releases
Search
-
17 Jan 2007
bioMérieux licenses technology from NorChip to launch a HPV test for cervical cancer risk detection
Marcy l'Etoile, France - January 17, 2007. bioMérieux and NorChip announced today that bioMérieux has entered into a worldwide exclusive license agreement for rights developed by NorChip to an innovat...
-
19 Dec 2006
The Board of Directors of bioMérieux, chaired by Alain Mérieux, has appointed Stéphane Bancel Directeur Général délégué (Chief Executive Officer) of bioMérieux starting January 1, 2007
Marcy l'Etoile, France - December 19, 2006. bioMérieux announced today the appointment of Stéphane Bancel as Directeur Général délégué (Chief Executive Officer). His new position will become effective...
-
19 Dec 2006
bioMérieux to Phase Out Microplate Immunoassay Production in the United States
Marcy l'Etoile, France - December 19, 2006. bioMérieux, a global leader in the field of in vitro diagnostics, today announced it will phase out production of microplate immunoassay business at its Dur...
-
15 Dec 2006
bioMérieux, first manufacturer worldwide to be officially recognized compliant with the ISO 11133 standard
Marcy l'Etoile, France - December 15, 2006. bioMérieux is the first manufacturer worldwide to be officially recognized as compliant with the XP CEN ISO/TS 11133 standard :“ Practical guidelines on pre...
-
07 Dec 2006
bioMérieux launches VIDAS® Troponin I Ultra
Marcy l'Etoile, France - December 7, 2006. bioMérieux, a major player in the field of in vitro diagnostics, is reinforcing its commitment to combating cardiovascular diseases by launching VIDAS Tropon...
-
24 Nov 2006
bioMérieux will be awarded up to €54.5 million by France’s Agence de l’Innovation Industrielle to pursue molecular biology research
Marcy l'Etoile, France - November 24, 2006. (MARCY-L'ETOILE, FRANCE - November 24, 2006) – bioMérieux today announced that it will be awarded up to €54.5 million over the next ten years by France’s Ag...